Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Its use is investigational, and it is not approved by any regulatory authority for the treatment of any specific medical condition
Developed by Eli Lilly under the code LY3437943, retatrutide has now progressed through Phase 3 clinical trials with landmark results published between December 2025 and May 2026, positioning it as one of the most closely watched metabolic research compounds in modern pharmacology
Possible Interactions : Glutathione may interact with certain medications used in the management of hyperthyroidism, such as antithyroid drugs
PubMed Cascio MG, et al
US$ 23.66
US$ 24.36
US$ 28.96
US$ 20.14
US$ 20.12
